RecruitingNCT07472738

Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases

An Observational Study for the Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases


Sponsor

Beijing Chao Yang Hospital

Enrollment

950 participants

Start Date

May 7, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This research study focuses on chronic airway diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. These conditions make it difficult for patients to breathe, but breathing difficulty (dyspnea) is often perceived very differently. Some patients may feel severe distress with mild breathing problems, while others might not notice significant breathing issues even when lung function is poor. This difference in perception is termed "dyspnea perception." The main goal of this study is to understand how dyspnea perception varies among patients with chronic airway diseases. The investigators aim to determine if patients can be grouped into different subtypes based on the perception of breathing difficulties. The study will also investigate how these subtypes relate to other treatable characteristics, such as blood cell counts, allergy test results, and findings from lung function tests and brain scans. Approximately 800 patients with COPD or asthma and 150 healthy volunteers will participate. Participants will answer questionnaires, undergo lung function tests, provide blood samples, and a subset will undergo a special brain scan (functional MRI). No new treatments will be assigned; instead, these characteristics will be observed and measured over time. It is hoped that this study will help doctors better understand chronic airway diseases and lead to more personalized management strategies for patients in the future.


Eligibility

Min Age: 20 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study aims to better understand and classify the different features (called "treatable traits") of chronic lung diseases like asthma and COPD. The goal is to identify specific patterns that can be individually targeted for treatment. Healthy volunteers are also invited to participate for comparison. **You may be eligible if...** - You are between 20 and 75 years old - You have been diagnosed with COPD or asthma according to standard guidelines - You are able and willing to give consent - OR you are a healthy person aged 20 or older with no history of chronic respiratory disease (for the control group) **You may NOT be eligible if...** - You had a respiratory infection or flare-up of your lung disease in the past 3 months - You have serious lung damage from conditions like severe bronchiectasis or tuberculosis - You had chest or abdominal surgery in the past 3 months - Your heart rate is over 120 beats per minute - You are currently being treated for tuberculosis - You are pregnant or breastfeeding - You have another serious uncontrolled illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERComprehensive Clinical Assessment

This is an observational study. No interventional treatment is assigned. Participants will undergo a comprehensive clinical assessment protocol, which includes: Measurement of dyspnea perception using standardized scales. Spirometry, lung volume, and diffusion capacity tests. Blood sample collection for complete blood count, total IgE, and allergen-specific IgE screening. Completion of quality of life and respiratory symptom questionnaires (e.g., CAT, mMRC, SGRQ, AQLQ). Fractional exhaled nitric oxide (FeNO) measurement. High-resolution computed tomography (HRCT) of the chest. Functional magnetic resonance imaging (fMRI) of the brain (for a subset of participants). Data on exacerbation history, comorbidities, and current medications will also be collected.


Locations(1)

Beijing Chao-Yang Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07472738


Related Trials